Singapore Studying the Feasibility, Reliability of Saliva Tests for Covid-19
In the News
Lucence Receives CLIA Certification for US Laboratory, Expands Access to Amplicon-Based Liquid Biopsy TestsDecember 10, 2020
Lucence Launches DeepMARK™ for Profiling of SARS-CoV-2 Subgenomic RNAOctober 7, 2020
Lucence Launches SAFER™ Technology Suite for Accurate COVID-19 Detection Using Naso-Oropharyngeal SalivaAugust 18, 2020
Lucence and Akribis Collaborate on COVID-19 Saliva Processing Automated Platform to Enable Mass TestingJuly 2, 2020
Singapore Studying the Feasibility, Reliability of Saliva Tests for Covid-19June 25, 2020
